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CURRENT THERAPEUTICS
Intralesional Steroid Injection: General
Considerations+
C T K Ho,* MBBS, MRCP
C S Lau, MD, MRCP
Department of Medicine
The University of Hong Kong
Summary
Local steroid injection is commonly used as an adjunctive therapy in articular disease and soft tissue
rheumatism. It may also be used as a bridge for earlier symptomatic relief in inflammatory arthritis, especially
rheumatoid arthritis. In this article, we describe some of the general considerations of this procedure. In the
next issues, we will describe specific techniques of injection of specific joints and soft tissue rheumatism
lesions. (HK Pract 1997; 19:425-429)
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Introduction
In 1940, Thorn' injected l0 mg
hydrocortisone into the knee joint of
a patient with rheumatoid arthritis
(RA). The knee improved locally,
but the patient also improved
generally and it was concluded that
the improvemen t resu l ted from
systemic absorption of the intra-
ar t icular ly injected material . No
further studies of intra-articular
glucocorticoid injections were done
unt i l the early 1950s.2 In 1961,
Hollander and associates3 reported a
series of more than 100,000
injections of joints, bursae, or tendon
sheaths in 4,000 pa t ien ts . The
researchers called for attention to
the usefulness of in t ra les ional
glucocorticoids as temporary,
p a l l i a t i v e , r e p e a t a b l e , l o c a l
adjunctive treatment for a variety of
rheumatic conditions.
Mechanism of action of in-
tralesional glucocorticoids
The anti- inflammatory mecha-
nisms of systemically administered
glucocorticoids are s t i l l not ful ly
unders tood . Even less is known
a b o u t t h e m e c h a n i s m s o f
intralesional glucocorticoids. After
an intralesional injection, a decrease
in erythema, swe l l i ng , heat and
tenderness of the tissues or joints is
demonstrated. An increase in
viscosity and hyaluronate concentra-
tion of the synovial f lu id is also
observed. In some s tudies ,
i n t r a l e s i o n a l i n j ec t ion of g l u c o -
corticoid has also been shown to
decrease synovial pe rmeab i l i t y .
Al though the disease process of
a r t h r i t i s may be suppressed to a
major degree, it is rarely "cured" by
+ Editor's Note: This article is the first in a series of three articles on local steroid injection for rheumatic disorders.
* Address for correspondence: Dr Carmen T K Ho, Registrar, Division of Rheumatology, Department of Medicine, The University of Hong Kong, Queen
Mary Hospital, Pokfulam Road, Hong Kong.
425
Intralesional Steroid Injection
CURRENT THERAPEUTICS
the corticosteroid injection. Other
conditions like capsulitis, bursitis, or
tendinitis may sometimes be "cured"
by single injections, but recurrence
of symptoms is not uncommon.
Indications of intralesional
steroid injections
Intra-articular and soft tissue
glucocorticoid injections are
considered adjunctive therapy for
most rheumatic conditions. When
one or few peripheral jo in t s are
i n f l a m e d or p a i n f u l f rom RA,
osteoarthritis (OA) or gouty arthritis,
glucocorticoid injections may provide
palliation and facilitate physical
therapy. Common soft t issue
rheumatism, for example, bicipital
tendinitis, shoulder capsulitis, tennis
elbow, de Querva in ' s disease
(stenosing tenosynovitis of the
extensor pollicis brevis and abductor
pollicis longus) and sometimes
trigger fingers can also be treated
with intralesional glucocorticoid
injections. Table 1 summarises the
common articular and non-articular
lesions which may be amenable to
local steroid injections.
Precautions and contraindi-
cations
Strict adherence to aseptic
procedures is required when one is
performing intralesional injections.
Because of potential tissue atrophy
with glucocorticoids, one should use
extreme caution when injecting near
peripheral nerves. Direct injection
of steroid to a nerve may result in
necrosis or atrophy.
There are no absolute contrain-
dications for soft tissue injections
except concurrent sepsis around the
site to be injected. However, more
cautions are needed prior to infusing
steroid into a joint. It is prudent to
exclude local or systemic sepsis. If
in doubt, the joint fluid should first
be examined for possible infection.
Unstable joint, traumatic arthritis
with in t ra -a r t icu la r fractures, and
severe juxtaarticular osteoporosis are
other important contraindications for
intra-ar t icular steroid in jec t ions .
Repeated steroid administration may,
in some cases, result in joint
instabili ty and should be avoided.
Table 2 shows the major con-
traindications for in t ra -a r t i cu la r
glucocorticoid injections.
Table 1: Indications of intralesional steroid injections
I. Articular disease:
Rheumatoid arthritis (juvenile and adult)
Crystal deposition disease (gout and pseudogout)
Systemic lupus erythromatosus and mixed connective tissue
disease with frank arthritis
Osteoarthritis
Shoulder periarthritis (adhesive capsulitis, frozen shoulder)
Tietze's syndrome
II. Nonarticular disease:
Shoulder
Elbow
Wrist & Hand -
Hip
Knee
Pelvis
Back
Foot
bicipital tendinitis
subacromial tendinitis
supraspinatus tendinitis
frozen shoulder
lateral epicondylitis - "tennis elbow"
medial epicondylitis -"golfer's elbow"
olecranon bursitis
ganglion
deQuervain's disease
trigger (snapping) fingers
carpal tunnel syndrome
trochanteric bursitis
prepatellar bursitis and neuritis
ischial bursitis
iliopectineal bursitis
fibromyalgia trigger points
Achilles tendinitis
Achilles bursitis
calcaneal bursitis
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Periarticular sepsis
Bacteriaemia
Unstable joints or severe joint destruction
Most spinal joints
Intra-articutar fractures
Septic arthritis: Do not forget the possibility of tuberculosis
Nondiarthrodial joints e.g. symphysis pubis
Marked juxta-articular osteoporosis
Failure to respond to prior injections
Multiplicity of severe joint inflammation
Bleeding disorders e.g. haemophiliacs
Efficacy of intralesional
steroid injections
A p p r o p r i a t e l y u sed , most
patients show a good response to
locally administered glucocorticoids.
However, the duration of symptom
improvement appears to be related to
the p r e p a r a t i o n u s e d . M e t h y l -
prednisolone and triamcinolone are
the commonest preparations used.
Table 3 s h o w s the l i s t of
glucocorticoid preparations available.
Dramatic improvement in symptoms
usual ly occurs within 12-24 hours,
although responses among patients
are extremely varied. Soft t issue
inflammatory conditions can be more
or less permanently eradicated by
judicious injections of steroids. On
the other hand, if one or two
injections prove ineffective or give
only short-lived benefit, there is no
logic in persis tent ly in jec t ing the
Intralesional preparations
Betamethasone sodium phosphate and acetate suspension, 6mg/ml
Dexamethasone sodium phosphate, 4mg/ml
Dexamethasone acetate, 8mg/ml
Hydrocortisone acetate, 25mg/ml
Methylprednisolone acetate, 20, 40, and 80 mg/ml (Depo-Medrol)
Prednisolone terbutate, 20mg/ml
Triamcinolone acetonide, 10 and 40mg/ml (Kenacort-10 and Kenacort-40)
Triamcinolone hexacetonide, 20mg/ml (Aristospan)
Prednisolone equivalents
40mg
30mg
80mg
5mg
25mg, 50mg, and 100mg
20mg
12.5mg and 50mg
25mg
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same joint. A weight-bearing joint
should be rested as much as possible
after an injection.
Most clinicians will agree with
the fo l lowing dosage (in mg
methylprednisolone acetate):
Small joints
e.g. interphalangeal joints 4-20 mg
Medium joints
e.g. wrist 20-40 mg
Large joints
e.g. knees, shoulders, ankles
40-80 mg
Soft tissue rheumatism:
frozen shoulder 20-40 mg
tennis/golfer's elbow 20-40 mg
bursitis 20-40 mg
It is important to remember not
to inject large volume of the agent
into a small joint which in
themselves can be painful.
General techniques for in-
tralesional steroid injection
Intralesional steroid injection is
a safe and simple procedure that can
be carried out in the c l in ic setting.
However, a no-touch technique and
the use of s teri le e q u i p m e n t and
aqueous solut ion are mandatory.
Prior to injection, it is important that
the pa t ien t is reassured and
positioned correctly. The objective
is to enter the selected injection site
and administer the steroid agent with
the minimal pain and trauma possible
to the structures. The use of local
anaesthetics (LA) such as lignocaine
prior to infiltration of steroid may be
1. Position patient. Palpate the specific area and select an injection
site.
2. Mark the skin with firm pressure by the edge of a nail or a
ballpoint pen (that has its ink cartridge and point retracted). This
will leave a mark for 5-15 minutes.
3. Draw up local anaesthetics and steroid agent. Cap the syringes to
ensure sterility.
4. Wash hands and swab the skin with alcohol pads or a sterile
solution such as hibitane. Do not touch the skin after swabbing.
5. Use 21-gauge needles for larger joints and 25-gauge needles for
smaller joints such as the finger joints.
6. Inject local anaesthetics to the site. Spraying the site with ethyl
chloride may be an alternative as the cooling effects of the spray
helps to numb the skin.
7. Aspirate any excess fluid (for intra-articular injections). Send
fluid for microscopical examination.
8. Take great care not to pull the needle out during changing of the
syringe after injection of local anaesthetics or aspiration of fluid.
9. Infuse the steroid preparation into the site. Ensure that there is
NO resistance during injection. The procedure MUST be halted
and the needle re-positioned if resistance is felt. Pain or
paraesthesia remote from the injection site should also call a halt
to the procedure.
10. Apply sterile dressing and advise the patient to avoid excessive
use of the limb in which the injection has taken place.
Table 5: Potential sequelae of intralesional glucocorticoid injections
1. Post-injection flare
2. Iatrogenic infection-very low incidence
3. Nerve damage
4. Tissue atrophy, fat necrosis, calcification
5. Tendon rupture
6. Pancreatitis- extremely rare
7. Radiological deterioration of joints: Charcot-like arthropathy
8. Posterior subcapsular cataract
428
Hong Kong Practitioner 19 (8) August 1997
useful as partial relief of symptoms
following injection of LA and also
confirms that the needle is correctly
placed. Additionally, the use of LA
may help to prevent post-injection
pain which may be a local
inflammatory reaction to steroid
crystals. Any excess joint fluid
should be aspirated and sent for
microbiology examination before
infiltration of the steroid preparation.
Table 4 shows a step-by-step
procedure for intralesional steroid
injections.
Potential complications of
intralesional steroid injec-
tions and recommendations
for repeat injections
Table 5 s u m m a r i s e s the
potential sequelae of intralesional
steroid injections. It is important to
remember to review the patient in 3-
4 days' time to assess the efficacy or
possible complications of the
injection.
As for repeat injections, a "rule
of 3" is highly recommended. Any
lesion should not be injected more
than 3 times, and for arthritis
conditions, repeat injections should
preferrably not be given within 3
months. However, for soft t issue
rheumatism, it may sometimes be
necessary to repeat an injection after
2-4 weeks.
Conclusion
In conclusion, appropriate use
of intralesional steroid injection is a
good and safe adjunctive therapy for
many art icular and soft tissue
rheumatism disorders. It involves
only simple techniques that can be
carried out as a bedside procedure by
most general practitioners. With care
to avoid sepsis, intralesional steroid
injection can be one of the most
grat ifying procedures for both
phys ic ians and pat ients . Most
conditions improve after single
treatment although some patients
may require to repeat administration
of the steroid agent to achieve
maximum effects. •
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